rs45464193
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM1PP2
The NM_000257.4(MYH7):c.5071G>A(p.Val1691Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,614,182 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1691G) has been classified as Uncertain significance.
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH7 | NM_000257.4 | c.5071G>A | p.Val1691Met | missense_variant | Exon 35 of 40 | ENST00000355349.4 | NP_000248.2 | |
MYH7 | NM_001407004.1 | c.5071G>A | p.Val1691Met | missense_variant | Exon 34 of 39 | NP_001393933.1 | ||
MHRT | NR_126491.1 | n.147C>T | non_coding_transcript_exon_variant | Exon 2 of 6 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251326Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135840
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461870Hom.: 0 Cov.: 34 AF XY: 0.0000261 AC XY: 19AN XY: 727238
GnomAD4 genome AF: 0.000118 AC: 18AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74478
ClinVar
Submissions by phenotype
Cardiomyopathy Uncertain:3
- -
This missense variant replaces valine with methionine at codon 1691 of the MYH7 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual affected with hypertrophic cardiomyopathy (PMID: 12707239) and in one individual affected with dilated cardiomyopathy (PMID: 19412328). This variant has been identified in 16/282712 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This missense variant replaces valine with methionine at codon 1691 of the MYH7 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with hypertrophic cardiomyopathy (PMID: 12707239) and in an individual affected with dilated cardiomyopathy (PMID: 19412328). This variant has been identified in 16/282712 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not provided Uncertain:2
- -
Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 222731; Landrum et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27247418, 20800588, 23403236, 19412328, 12707239) -
Cardiovascular phenotype Uncertain:2
- -
The p.V1691M variant (also known as c.5071G>A), located in coding exon 33 of the MYH7 gene, results from a G to A substitution at nucleotide position 5071. The valine at codon 1691 is replaced by methionine, an amino acid with highly similar properties. This variant has been detected in individuals from hypertrophic cardiomypathy and dilated cardiomyopathy cohorts; however, clinical details were limited (Richard P et al. Circulation, 2003 May;107:2227-32; Hershberger RE et al. Clin Transl Sci, 2008 May;1:21-6). This variant has also been detected in genome sequencing and population-based cohorts in individuals not indicated as having overt cardiomyopathy (Bick AG et al. Am. J. Hum. Genet., 2012 Sep;91:513-9; Kwak SH et al. Exp. Mol. Med., 2017 07;49:e356). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Left ventricular noncompaction cardiomyopathy Uncertain:1
- -
Hypertrophic cardiomyopathy Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1691 of the MYH7 protein (p.Val1691Met). This variant is present in population databases (rs45464193, gnomAD 0.02%). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy and dilated cardiomyopathy (PMID: 12707239, 19412328, 27247418, 37652022). ClinVar contains an entry for this variant (Variation ID: 222731). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MYH7 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at